Drug
Signatera Test
Signatera Test: highest development phase Phase 2/3, developed by Natera. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Natera
Trials
| Drug | Phase | Indication |
|---|---|---|
| Signatera test NCT05174169 | Phase 2/3 | Stage III Colon Cancer |
Latest
No recent events.
Follow Signatera Test on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.